We seek renewal of a highly productive multiple-PI research program involving the analysis and engineering of a broad class of monooxygenases from diverse natural product pathways. Cytochrome P450s are one of the most widely distributed groups of enzymes in nature, catalyzing the oxidation of natural product and xenobiotic small molecules. Although hundreds of P450s have been examined in the oxidative metabolism of xenobiotics and steroids, only a small number have been studied in bacterial secondary metabolism, especially in macrolide antibiotic biosynthetic pathways. In most of these systems, hydroxylation and/or epoxidation reactions occur in the late stages of biosynthesis after macrolide formation by the polyketide synthase (PKS). In addition to significant increases in biological potency, hydroxylation provides potential sites for chemical modification and further enhancement of bioactivities. Thus, the creation of novel macrolide analogs through in vivo metabolic engineering and in vitro chemoenzymatic synthesis warrants a concomitant effort towards the development of monooxygenases with defined substrate specificities.
The aim of the proposed work is to expand our understanding of the substrate flexibility and functionality of a range of P450 monooxygenases from macrolide and select other natural product systems. Our progress over the first period of support has provided fascinating new insights into the molecular mechanisms of these biocatalysts, and their ability to generate novel products by hydroxylation, and epoxidation of natural and unnatural substrates. This information will direct protein engineering/substrate engineering efforts to better understand the function and positional specificity of the enzyme, as well as its ability to catalyze a range of oxidative reactions. Our program brings complementary approaches of synthetic chemistry to create diverse substrates, biochemistry to investigate and develop engineered monoxygenases with versatile substrate selectivity, and X-ray and NMR- based methods to obtain high resolution structural information for mechanistic understanding of these remarkable proteins.
Specific Aim 1. Assess the impact of steric, electronic and directing group factors on catalytic promiscuity in the P450 PikC using a series of synthetic analogs of the natural macrolide substrate YC-17. Employ X-ray and solution NMR based structural biology approaches to gain detailed insights into binding parameters, protein-substrate dynamics, and the mechanistic basis for regio- and stereochemical specificity of natural and unnatural substrates.
Specific Aim 2. Expand access to diverse synthetic substrates for a range of new P450 enzymes to investigate regio- and stereochemical details of monooxygenase-catalyzed hydroxylation and epoxidation reactions.
Specific Aim 3. Pursue biochemical and structural studies of mixed-function iterative P450 enzymes to analyze substrate specificity and kinetics, as well as to investigate binding and catalytic mechanisms.

Public Health Relevance

The studies proposed will broaden our knowledge of an important class of enzymes whose catalytic capabilities lead to important new medicinal agents in the form of natural product antibiotics and anticancer drugs. This new information will be used to generate novel biologically active compounds for the discovery and development of new pharmaceutical agents to fight human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM078553-06
Application #
8458929
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Gerratana, Barbara
Project Start
2007-05-15
Project End
2016-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
6
Fiscal Year
2013
Total Cost
$410,081
Indirect Cost
$89,966
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
DeMars 2nd, Matthew D; Sheng, Fang; Park, Sung Ryeol et al. (2016) Biochemical and Structural Characterization of MycCI, a Versatile P450 Biocatalyst from the Mycinamicin Biosynthetic Pathway. ACS Chem Biol 11:2642-54
Chemler, Joseph A; Tripathi, Ashootosh; Hansen, Douglas A et al. (2015) Evolution of Efficient Modular Polyketide Synthases by Homologous Recombination. J Am Chem Soc 137:10603-9
Bernard, Steffen M; Akey, David L; Tripathi, Ashootosh et al. (2015) Structural basis of substrate specificity and regiochemistry in the MycF/TylF family of sugar O-methyltransferases. ACS Chem Biol 10:1340-51
Narayan, Alison R H; Jiménez-Osés, Gonzalo; Liu, Peng et al. (2015) Enzymatic hydroxylation of an unactivated methylene C-H bond guided by molecular dynamics simulations. Nat Chem 7:653-60
Wang, Hengbin; Negretti, Solymar; Knauff, Allison R et al. (2015) Exo-selective reductive macrocyclization of ynals. Org Lett 17:1493-6
Negretti, Solymar; Narayan, Alison R H; Chiou, Karoline C et al. (2014) Directing group-controlled regioselectivity in an enzymatic C-H bond oxygenation. J Am Chem Soc 136:4901-4
Zhang, Wei; Liu, Yi; Yan, Jinyong et al. (2014) New reactions and products resulting from alternative interactions between the P450 enzyme and redox partners. J Am Chem Soc 136:3640-6
Narayan, Alison R H; Sherman, David H (2013) Chemistry. Re-engineering nature's catalysts. Science 339:283-4
García-Fernández, Esther; Frank, Daniel J; Galán, Beatriz et al. (2013) A highly conserved mycobacterial cholesterol catabolic pathway. Environ Microbiol 15:2342-59
Li, Shengying; Tietz, Drew R; Rutaganira, Florentine U et al. (2012) Substrate recognition by the multifunctional cytochrome P450 MycG in mycinamicin hydroxylation and epoxidation reactions. J Biol Chem 287:37880-90

Showing the most recent 10 out of 40 publications